Business Standard

Wednesday, January 15, 2025 | 10:00 PM ISTEN Hindi

Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap (    %)
                             
Nifty Smallcap (    %)
                             
Nifty Bank (    %)
                             
Home / Markets / Parenteral Drugs (India) Ltd

Parenteral Drugs (India) Share Price

Know More
BSENSE

₹3.39 0.00 (0.00%)

04:01 PM, 21-Aug-2023
Stock not traded

BSE : 524689

NSE : PDPL

Sector : Health care

ISIN Code : INE904D01019

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 21-Aug-2023 | 04:01 PM IST

Add to PortfolioAdd to Watchlist

Market Cap (₹ Cr)

10

Traded Value (₹ Cr)

0.00

Volume (Shares)

1,250

Face Value (₹)

10

52-Week High (₹)

3.39

52-Week High Date

21-Aug-2023

52-Week Low (₹)

0.00

52-Week Low Date

Invalid date

All Time High (₹)

399.95

All Time High Date

10-Nov-2010

All Time Low (₹)

0.38

All Time Low Date

25-Jan-1999

Parenteral Drugs (India) Ltd

Parenteral Drugs (India) Limited was incorporated in 1983 as a private limited company. In 1989 the Company established their first unit to manufacture I V Fluids in Polypropylene containers with a capacity of 18 lakh bottles per annum. In March 1994 the company was converted into a public limited company. Parenteral Drugs (India) is an India-based pharmaceutical company. The Company manufactures and markets pharmaceutical products in India including solid and liquid orals such as antibiotics and anti-bacterial anti-ulcerant analgesics/anti-inflammatory multivitamins and minerals anxiolyic antiprotozoal anticold anthelmintic anti-histaminic muscle relaxant cardiac antidiabetic cough syrup a...
Read More

Market News

Diversified revenue mix, margin gains positive for BSE amidst volume hit

4 min read

Maruti Suzuki stock hits 12-week high; rallies nearly 4% on healthy outlook

3 min read

Analysts raise earnings estimates of HDFC AMC after stellar Q3 show

2 min read

Performance slump halts Quant MF's dream run, AUM growth lags in Q3

3 min read

J Kumar Infraprojects wins project of Rs 1073 cr from NBCC (India)

More

Parenteral Drugs Announcement

Pursuant to Regulation 30 of SEBI LODR Regulations 2015 we would like to inform that the 22nd CoC of Parenteral Drugs (India) Limited was held on Thursday 05.12.2024 at 5:30 p.m.

Pursuant to Regulation 30 SEBI (LODR) Regulations 2015 and in accordance with the requirements of Schedule III of the Listing Regulations we wish to inform you that the 19th CoC meeting of Parenteral Drugs (India) Limited is scheduled to be held on Thursday 05.12.2024 at 5:30 p.m.

Pursuant to Regulation 30 of SEBI (Listing obligation and Disclosure Requirements) Regulations 2015 (Listing Regulations) and in accordance with the requirements of sub-clause 16(g) of Para A of Part A of Schedule III of Listing Regulations we would like to inform that the Twentieth Meeting of Committee of Creditors (CoC) of Parenteral Drugs (India) Limited the Corporate Debtor was held on Monday 09th September 2024 at 05:30 P.M.

Pursuant to Regulation 30 of SEBI(Listing Obligation and Disclosure Requirements) 2015(Listing Regulations) and in accordance with the requirements of the sub-clause 16(g) of Para A of Part A of Schedule III of Listing Regulations we would like to inform that the Nineteenth Meeting of Committee of Creditors (CoC) of Parental Drugs(India) Limited the Corporate Debtor was held on Monday 12th August 2024 at 2:30 P.M.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) and in accordance with the requirements of sub -clause 16(g) of Para A of Part A of Schedule III of Listing Regulations we wish to inform you that the Nineteenth meeting of Committee of Creditors (CoC) of Parenteral Drugs (India) Limited the Corporate Debtor is Scheduled to be held on Monday 12th August 2024 at 02:30 P.M.

More

Parenteral Drugs (India) Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

10

EPS - TTM (₹) [C]

0.00

P/E Ratio (X) [C]

-

Face Value (₹) 10
Latest Dividend (%)20.00
Latest Dividend Date 13-Sep-2010
Dividend Yield (%) -
Book Value Share (₹) [C]-300.50
P/B Ratio (₹) [C]-0.01

[*C] Consolidated [*S] Standalone

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
DSP Midcap Fund (G) 2.85 1,46,927 0.26

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

3.08

3.39

Week Low/High (₹)

0.00

3.39

Month Low/High (₹)

0.00

3.39

Year Low/High (₹)

0.00

3.39

All time Low/High (₹)

0.38

400.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week%%-1.82-2.01%
1 Month%%-6.59-6.28%
3 Month%%-6.23-7.36%
6 Month%%-4.89-5.59%
1 Year%%4.635.05%
3 Year%%25.3227.16%

Company Info

Company Information

Chairman : Manoharlal Gupta

Whole-time Director : Govind Das Garg

Independent Director : Dharam Pal Khanna

Independent Director : Dilip Kumar Sinha

Non Executive Director : Anil Mittal

Independent Director : Manish Verma

Managing Director & CFO : Vinod Kumar Gupta

Independent Director : Deepali Garhewal

Independent Director : Chhaya Gupta

Registered Office: 340 Laxmi Plaza Laxmi Indl Est, New Link Road Andheri (West),Mumbai,Maharashtra-400053 Ph: 91-022-61725900-1

Email:pdpl_mumbai@pdindia.com

URL:http://www.pdindia.com

FAQs about Parenteral Drugs (India) Ltd

1. What's the Parenteral Drugs (India) Ltd share price today?
Parenteral Drugs (India) Ltd share price was Rs 3.39 at 04:01 PM IST on 21st Aug 2023. Parenteral Drugs (India) Ltd share price was up by 0.00% over the previous closing price of Rs 3.39. Parenteral Drugs (India) Ltd share price trend:

  • Last 1 Month: Parenteral Drugs (India) Ltd share price moved up by % on _
  • Last 3 Months: Parenteral Drugs (India) Ltd share price moved up by % on _
  • Last 12 Months: Parenteral Drugs (India) Ltd share price moved up by % on _
  • Last 3 Years: Parenteral Drugs (India) Ltd price moved up by % on _


2. How can I quickly analyse the performance of the Parenteral Drugs (India) Ltd stock?
The performance of the Parenteral Drugs (India) Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is _
  • Price to book value ratio is -0.01
  • Dividend yield of 0.00
  • The EPS (trailing 12 months) of the Parenteral Drugs (India) Ltd stock is Rs 0.00


3. What is the market cap of Parenteral Drugs (India) Ltd?
Parenteral Drugs (India) Ltd has a market capitalisation of Rs 10 crore.


4. What is Parenteral Drugs (India) Ltd's 52-week high/low share price?
The Parenteral Drugs (India) Ltd’s 52-week high share price is Rs 3.39 and 52-week low share price is Rs 0.00.


5. Is the Parenteral Drugs (India) Ltd profitable?
On a consolidated basis, Parenteral Drugs (India) Ltd reported a profit of Rs 23.81 crore on a total income of Rs 54.02 crore for the quarter ended 2022. For the year ended Mar 2022, Parenteral Drugs (India) Ltd had posted a profit of Rs 23.81 crore on a total income of Rs 54.02 crore.


6. Which are Parenteral Drugs (India) Ltd’s peers in the Health care sector?
Parenteral Drugs (India) Ltd’s top 5 peers in the Health care sector are Unjha Formul., Venmax Drugs, Hind.Bio Science, Cian Healthcare, Brawn Biotech.


7. Who owns how much in Parenteral Drugs (India) Ltd?
Key changes to the Parenteral Drugs (India) Ltd shareholding are as follows:

  • Promoter holding in Parenteral Drugs (India) Ltd has gone up to 73.29 per cent as of Mar 2022 from 73.28 per cent as of Jun 2021.

HOT STOCKS
TOP SECTIONS
KEY EVENTS
Copyrights © 2025 Business Standard Private Ltd. All rights reserved
LinkedIN Icon